OVARIAN CANCER and US: Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.

Sunday, July 29, 2012

Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.

http://www.ncbi.nlm.nih.gov/m/pubmed/22836511/?i=4&from=ovarian%20cancer

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.